Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT07665515 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
HGSOC
HGS Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Interventions

BIOLOGICAL: CryptiVax-1001

Sponsor

Epitopea Ltd